Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

376
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
376
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

257
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
257
Pharmacovigilance01:19

Pharmacovigilance

833
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
833
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

128
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
128
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

5.2K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.2K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

984
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
984

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Can Technology Simplify Aging Care-or Just Shift the Complexity?

The Senior care pharmacist·2026
Same author

A Randomized Controlled Trial of Self-Guided Digital Written Imaginal Exposure Therapy for Eating Disorders in Patients Recently Discharged From Higher Level Specialty Eating Disorder Care.

The International journal of eating disorders·2026
Same author

Comprehensive Geriatric Assessment and Medication "Appropriateness".

The Senior care pharmacist·2026
Same author

Factors Associated with Healthcare Utilization in Children with Sickle Cell Disease in Saudi Arabia.

International journal of environmental research and public health·2026
Same author

Caring for the Caregiver.

The Senior care pharmacist·2026
Same author

Reflecting on the Value of Mentors.

The Senior care pharmacist·2026

Related Experiment Video

Updated: Jul 4, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.6K

Statistical methods for assessing drug interactions using observational data.

Qian Xu1,2, Demetra Antimisiaris3, Maiying Kong1

  • 1Department of Bioinformatics and Biostatistics, University of Louisville School of Public Health and Information Sciences, Louisville, KY, USA.

Journal of Applied Statistics
|January 29, 2024
PubMed
Summary

This study introduces marginal structural models to evaluate the causal effects and interactions of multiple drugs, crucial for managing complex conditions and minimizing adverse drug events.

Keywords:
Drug interactiongeneralized propensity scoremarginal structural modelsmultinomial logistic regression

More Related Videos

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.8K

Related Experiment Videos

Last Updated: Jul 4, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.6K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.8K

Area of Science:

  • Pharmacology and Pharmacoepidemiology
  • Biostatistics and Health Data Science

Background:

  • Polydrug use is common in patients with multiple conditions, posing risks of severe side effects.
  • Combination treatments are vital for managing severe diseases like cancer and chronic conditions.
  • Electronic health records offer valuable data for analyzing drug interactions.

Purpose of the Study:

  • To propose and validate marginal structural models for assessing the average treatment effect and causal interaction of two drugs.
  • To control for confounding variables when evaluating drug effects using observational data.
  • To provide a robust statistical framework for understanding complex drug-drug interactions.

Main Methods:

  • Utilizing marginal structural models to estimate causal effects and interactions.
  • Employing the inverse probability of treatment weighting (IPTW) approach for weighted likelihood estimation.
  • Conducting simulation studies to assess the consistency and performance of the proposed method.

Main Results:

  • The proposed marginal structural models consistently estimate causal parameters.
  • Simulation studies confirmed the reliability of the method in handling confounding.
  • Case studies demonstrated the application in analyzing drug effects on patient outcomes and biomarkers.

Conclusions:

  • Marginal structural models offer a reliable approach for assessing causal drug interactions in observational studies.
  • The IPTW method effectively controls for confounding, enabling accurate estimation of average treatment effects.
  • This methodology can inform clinical practice by elucidating the joint effects of medications in real-world patient populations.